Bill Summary & Status for the 106th Congress

NEW SEARCH | HOME | HELP
H.R.4772
Sponsor: Rep Owens, Major R.(introduced 6/27/2000)
Latest Major Action: 7/19/2000 Referred to House subcommittee
Title: To provide for prices of pharmaceutical products that are fair to the producer and the consumer, and for other purposes.
Jump to: Titles, Status, Committees, Related Bill Details, Amendments, Cosponsors, Summary
TITLE(S):  (italics indicate a title for a portion of a bill)
STATUS: (color indicates Senate actions)
6/27/2000:
Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
6/27/2000:
Referred to House Commerce
7/19/2000:
Referred to the Subcommittee on Health and Environment.
6/27/2000:
Referred to House Judiciary
COMMITTEE(S):
RELATED BILL DETAILS:

***NONE***

AMENDMENT(S):

***NONE***

COSPONSORS(5), ALPHABETICAL [followed by Cosponsors withdrawn]:     (Sort: by date)

Rep Brady, Robert - 7/27/2000 Rep Jones, Stephanie Tubbs - 9/26/2000
Rep Lee, Barbara - 9/26/2000 Rep Norton, Eleanor Holmes - 9/26/2000
Rep Payne, Donald M. - 7/27/2000

SUMMARY AS OF:
6/27/2000--Introduced.

Pharmaceutical Products Price Equity Act - Directs the President to issue such orders and regulations, and establish such procedures and reporting requirements, as the President determines to be appropriate to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions. Authorizes appropriations.